GemVax & KAEL Co.,Ltd.
Clinical-stage biopharma developing therapeutics for neurodegenerative diseases.
082270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7082270000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노11로 58, 대전광역시
- Website:
- https://gemvax.com/
- Sector:
- Manufacturing
Description
GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-18 00:00 |
소송등의판결ㆍ결정
|
Korean | 4.8 KB | ||
| 2021-03-16 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.8 KB | ||
| 2021-03-16 00:00 |
주주총회소집결의
|
Korean | 7.8 KB | ||
| 2021-03-16 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.4 KB | ||
| 2021-03-16 00:00 |
주주총회소집공고
|
Korean | 113.3 KB | ||
| 2021-03-16 00:00 |
의결권대리행사권유참고서류
|
Korean | 89.5 KB | ||
| 2021-03-12 00:00 |
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2021-03-08 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 148.7 KB | ||
| 2021-03-02 00:00 |
[기재정정]감사보고서제출(2017사업연도)
|
Korean | 32.8 KB | ||
| 2021-03-02 00:00 |
[기재정정]감사보고서제출(2018사업연도)
|
Korean | 35.6 KB | ||
| 2021-03-02 00:00 |
[기재정정]사업보고서 (2017.12)
|
Korean | 615.9 KB | ||
| 2021-03-02 00:00 |
[기재정정]반기보고서 (2018.06)
|
Korean | 1.7 MB | ||
| 2021-03-02 00:00 |
[기재정정]사업보고서 (2018.12)
|
Korean | 601.6 KB | ||
| 2021-01-28 00:00 |
소송등의제기ㆍ신청(경영권분쟁소송)(장부등열람허용가처분신청)
|
Korean | 6.7 KB | ||
| 2021-01-27 00:00 |
투자판단관련주요경영사항(알츠하이머병 치료제로서 GV 1001의 국내 제3상 임상시험계획 승인 신청)
|
Korean | 10.1 KB |
Automate Your Workflow. Get a real-time feed of all GemVax & KAEL Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GemVax & KAEL Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GemVax & KAEL Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
